In response to an article detailing the CV risks of long-term
rofecoxib therapy, Peter Leman felt impelled to write a rapid response
letter stating that rofecoxib can be used to treat acute injury without
any risk of serious adverse effects. Peter Leman concludes his letter by
stating that "for acute injury at least, it seems that rofecoxib is
probably as good as, and perhaps a bit better than, a non-selective drug."
What Peter Leman fails to mention that is that many NSAIDS are much
cheaper than rofecoxib and they can be readily obtained over-the-counter
without a prescription. Why should a person use an expensive drug like
rofecoxib for an acute injury when so many cheaper, and equally effective,
NSAIDs are available?
Rapid Response:
Why use rofecoxib for acute injury?
In response to an article detailing the CV risks of long-term
rofecoxib therapy, Peter Leman felt impelled to write a rapid response
letter stating that rofecoxib can be used to treat acute injury without
any risk of serious adverse effects. Peter Leman concludes his letter by
stating that "for acute injury at least, it seems that rofecoxib is
probably as good as, and perhaps a bit better than, a non-selective drug."
What Peter Leman fails to mention that is that many NSAIDS are much
cheaper than rofecoxib and they can be readily obtained over-the-counter
without a prescription. Why should a person use an expensive drug like
rofecoxib for an acute injury when so many cheaper, and equally effective,
NSAIDs are available?
Jeff Mann
Competing interests:
None declared
Competing interests: No competing interests